A new formula CPC22 regulates bone loss, hot flashes, and dysregulated lipid metabolism in ovariectomized postmenopausal mice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and objective: A new formular CPC22 consists of Cynanchum wilfordii root, Pueraria thomsonii flower, and Citrus unshiu peel and has been developed to improve the postmenopausal symptoms. The research intended to evaluate whether CPC22 would regulate bone loss, hot flashes, and dysregulated lipid metabolism in ovariectomized (OVX) postmenopausal mice. Method: The OVX mice were orally administered with CPC22 daily for 7 weeks. Results: CPC22 regulated OVX-induced bon loss by enhancing serum osteoprotegerin, alkaline phosphatase, and osteocalcin levels and diminishing serum receptor-activator of the NF-κB ligand (RANKL), collagen type 1 cross-linked N-telopeptide, and tartrate-resistant acid phosphatase levels. As a result of CPC22 treatment, notable decreases in tail skin temperature and rectal temperature were observed, along with diminishment in hypothalamic RANKL and monoamine oxidase A levels and enhancement in hypothalamic serotonin (5-HT), norepinephrine, dopamine, 5-HT2A, and estrogen receptor-β levels. CPC22 enhanced levels of serum estrogen and diminished levels of serum follicle-stimulating hormone and luteinizing hormone. CPC22 regulated levels of serum lipid metabolites, including total cholesterol, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol. Furthermore, CPC22 diminished levels of serum blood urea nitrogen, creatine kinase, alanine transaminase, aspartate aminotransferase, and lactate dehydrogenase and restored vaginal dryness without affecting uterus atrophy index and vagina weights. Conclusion: Therefore, these results indicated that CPC22 improves OVX-induced bone loss, hot flashes, and dysregulated lipid metabolism by compensating for estrogen deficiency without side effects, suggesting that CPC22 may be used for the prevention and treatment of post menopause.
Abstract
Background and objective: A new formular CPC22 consists of Cynanchum wilfordii root, Pueraria thomsonii flower, and Citrus unshiu peel and has been developed to improve the postmenopausal symptoms. The research intended to evaluate whether CPC22 would regulate bone loss, hot flashes, and dysregulated lipid metabolism in ovariectomized (OVX) postmenopausal mice. Method: The OVX mice were orally administered with CPC22 daily for 7 weeks. Results: CPC22 regulated OVX-induced bon loss by enhancing serum osteoprotegerin, alkaline phosphatase, and osteocalcin levels and diminishing serum receptor-activator of the NF-κB ligand (RANKL), collagen type 1 cross-linked N-telopeptide, and tartrate-resistant acid phosphatase levels. As a result of CPC22 treatment, notable decreases in tail skin temperature and rectal temperature were observed, along with diminishment in hypothalamic RANKL and monoamine oxidase A levels and enhancement in hypothalamic serotonin (5-HT), norepinephrine, dopamine, 5-HT2A, and estrogen receptor-β levels. CPC22 enhanced levels of serum estrogen and diminished levels of serum follicle-stimulating hormone and luteinizing hormone. CPC22 regulated levels of serum lipid metabolites, including total cholesterol, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol. Furthermore, CPC22 diminished levels of serum blood urea nitrogen, creatine kinase, alanine transaminase, aspartate aminotransferase, and lactate dehydrogenase and restored vaginal dryness without affecting uterus atrophy index and vagina weights. Conclusion: Therefore, these results indicated that CPC22 improves OVX-induced bone loss, hot flashes, and dysregulated lipid metabolism by compensating for estrogen deficiency without side effects, suggesting that CPC22 may be used for the prevention and treatment of post menopause.
참고문헌 (48)
- Hoga L, "Women's experience of menopause : a systematic review of qualitative evidence", JBI Database System Rev Implement Rep, 13(8), pp.250~337 (2015)
- del Giorno C, "Effects of Trifolium pratense on the climacteric and sexual symptoms in postmenopause women", Rev Assoc Med Bras(1992), 56(5), pp.558~562 (2010)
- Kang SJ, "Anti-climacterium effects of pomegranate concentrated solutions in ovariectomized ddY mice", Exp Ther Med, 13(4), pp.1249~1266 (2017)
- Wolff LP, "Endometrial evaluation in menopausal women after six months of isoflavones", Rev Assoc Med Bras(1992), 52(6), pp.419~423 (2006)
- Kanis JA, "European guidance for the diagnosis and management of osteoporosis in postmenopausal women", Osteoporos Int, 30(1), pp.3~44 (2019)
- He B, "Causal Effect of Blood Pressure on Bone Mineral Density and Fracture : A Mendelian Randomization Study", Front Endocrinol(Lausanne), 12, pp.716681~ (2021)
- Kling JM, "Osteoporosis prevention, screening, and treatment : a review", J Womens Health(Larchmt), 23(7), pp.563~572 (2014)
- Berin E, "Resistance training for hot flushes in postmenopausal women : A randomised controlled trial", Maturitas, 126, pp.55~60 (2019)
- Shen W, "Treatment strategies for hot flushes", Expert Opin Pharmacother, 10(7), pp.1133~1144 (2009)
- Freedman RR, "Menopausal hot flashes : mechanisms, endocrinology, treatment", J Steroid Biochem Mol Biol, 142, pp.115~120 (2014)
- Steininger TL, "Subregional organization of preoptic area", anterior hypothalamic projections to arousal-related monoaminergic cell groups, 2001, pp.429(4), 638~653
- Wang W, "Estradiol Valerate and Remifemin ameliorate ovariectomy-induced decrease in a serotonin dorsal raphe-preoptic hypothalamus pathway in rats", Ann Anat, 208, pp.31~39 (2016)
- Kalkan R, "RANKL is a new Epigenetic Biomarker for the Vasomotor Symptom During Menopause", Balkan J Med Genet, 23(1), pp.51~56 (2020)
- Huang D, "Chinese medicine Bazi Bushen capsule improves lipid metabolism in ovariectomized female ApoE-", -mice, 2020, pp.9(3), 1073~1083
- Sima P, "Atherosclerosis as autoimmune disease", Ann Transl Med, 6(7), pp.116~ (2018)
- Marchand GB, "Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women", Am J Physiol Endocrinol Metab, 314(5), pp.E448~E456 (2018)
- Thaung Zaw JJ, "Postmenopausal health interventions : Time to move on from the Women's Health Initiative?", Ageing Res Rev, 48, pp.79~86 (2018)
- Jeong HJ, "PCE17 and its active compounds exert an anti-osteoporotic effect through the regulation of receptor activator of nuclear factor-κB ligand in ovariectomized mice", J Food Biochem, 42(5), pp.e12561~ (2018)
- Fernandez E, "Hormone replacement therapy and cancer risk : a systematic analysis from a network of case-control studies", Int J Cancer, 105(3), pp.408~412 (2003)
- Mennenga SE, "Understanding the cognitive impact of the contraceptive estrogen Ethinyl Estradiol : tonic and cyclic administration impairs memory, and performance correlates with basal forebrain cholinergic system integrity", Psychoneuroendocrinology, 54, pp.1~13 (2015)
- Han NR, "Improvement effects of a mixed extract of flowers of Pueraria thomsonii Benth. and peels of Citrus unshiu Markovich on postmenopausal symptoms of ovariectomized mice", Biomed Pharmacother, 103, pp.524~530 (2018)
- Lee H, "Effects of Cynanchum wilfordii on osteoporosis with inhibition of bone resorption and induction of bone formation", Mol Med Rep, 17(3), pp.3758~3762 (2018)
- Lim DW, "Preventive effects of Citrus unshiu peel extracts on bone and lipid metabolism in OVX rats", Molecules, 19(1), pp.783~794 (2014)
- 이규옥, "Effects of Aqueous Extracts of Cynanchum wilfordii in Rat Models for Postmenopausal Hot Flush", Preventive Nutrition and Food Science, 21(4), pp.373~377 (2016), 한국식품영양과학회[DOI]
- Lim JH, "Dp44mT regulates the levels of inflammatory mediators through blocking NF-κB nuclear translocation in LPS-stimulated RAW 264.7 macrophages", In Vitro Cell Dev Biol Anim, 57(3), pp.332~341 (2021)
- 김민호, "Effect of KH-BaRoKer-SeongJangTang based on traditional medicine theory on longitudinal bone growth", 셀메드, 4(2), pp.14~14 (2014), 셀메드 세포교정의약학회[DOI]
- Stearns V, "Hot flushes", Lancet, 360(9348), pp.1851~1861 (2002)
- McEwen BS, "Estrogen actions in the central nervous system", Endocr Rev, 20(3), pp.279~307 (1999)
- Shuto H, "The statins fluvastatin and pravastatin exert anti-flushing effects by improving vasomotor dysfunction through nitric oxide-mediated mechanisms in ovariectomized animals", Eur J Pharmacol, 651, pp.234~239 (2011)
- Tataryn IV, "LH, FSH and skin temperaure during the menopausal hot flash", J Clin Endocrinol Metab, 49(1), pp.152~154 (1979)
- Zhang Y, "Angiogenesis Changes in Ovariectomized Rats with Osteoporosis Treated with Estrogen Replacement Therapy", Biomed Res Int, 2019, pp.1283717~ (2019)
- Geng Q, "Pyrroloquinoline Quinone Prevents Estrogen Deficiency-Induced Osteoporosis by Inhibiting Oxidative Stress and Osteocyte Senescence", Int J Biol Sci, 15(1), pp.58~68 (2019)
- Dalal PK, "Postmenopausal syndrome", Indian J Psychiatry, 57(Suppl 2), pp.S222~S232 (2015)
- Hildebrandt T, "Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa", Clin Psychol Rev, 30(6), pp.655~668 (2010)
- Charoenphandhu N, "Upregulated mRNA levels of SERT, NET, MAOB, and BDNF in various brain regions of ovariectomized rats exposed to chronic aversive stimuli", Mol Cell Biochem, 375, pp.49~58 (2013)
- Hanada R, "Central control of fever and female body temperature by RANKL", RANK, 2009, pp.462(7272), 505~509
- Krause MS, "Hormonal and nonhormonal treatment of vasomotor symptoms", Obstet Gynecol Clin North Am, 42(1), pp.163~179 (2015)
- Sicat BL, "Nonhormonal alternatives for the treatment of hot flashes", Pharmacotherapy, 24(1), pp.79~93 (2004)
- Shumilov M, "Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies", Int J Pharm, 387, pp.26~33 (2010)
- Perich T, "Menopause and illness course in bipolar disorder : A systematic review", Bipolar Disord, 19(6), pp.434~443 (2017)
- Garcia AN, "The timing and duration of estradiol treatment in a rat model of the perimenopause : Influences on social behavior and the neuromolecular phenotype", Horm Behav, 97, pp.75~84 (2018)
- Kim HY, "Antidepressant-like effect of Ikwitang involves modulation of monoaminergic systems", Mol Med Rep, 13(3), pp.2815~2820 (2016)
- Sun B, "An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause", J Vis Exp, (150) (2019)[DOI]
- Lin S, "The effects of atorvastatin on the prevention of osteoporosis and dyslipidemia in the high-fat-fed ovariectomized rats", Calcif Tissue Int, 96(6), pp.541~551 (2015)
- Kim JH, "Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice", Endocr J, 62(6), pp.531~542 (2015)
- Kang S, "Safety Assessment of Endocrine Disruption by Menopausal Health Functional Ingredients", Healthcare(Basel), 9(10), pp.1376~ (2021)
- Kamiya T, "Evaluation of the Estrogenic Activity of Pueraria(Kudzu)Flower Extract and Its Major Isoflavones Using ER-Binding and Uterotrophic Bioassays", Pharmacology & Pharmacy, 4(2), pp.255~260 (2013)
- Schlemmer CK, "Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat", Prostaglandins Leukot Essent Fatty Acids, 61(6), pp.381~390 (1999)
